Tech Company Financing Transactions

Catabasis Pharmaceuticals Funding Round

Advanced Technology Ventures, Clarus and MedImmune Ventures invested in a $32.4 million Series B funding round for Catabasis Pharmaceuticals. The funding round was announced by the company on 11/14/2013.

Transaction Overview

Company Name
Catabasis Pharmaceuticals
Announced On
11/14/2013
Transaction Type
Venture Equity
Amount
$32,400,000
Round
Series B
Investors

Advanced Technology Ventures (Christian Cortis)

Clarus (Jeffrey Leiden)

MedImmune Ventures (Maggie LeFlore)

SV Health Investors (Michael Ross)

Proceeds Purpose
Catabasis plans to use proceeds from this financing to support the development of its lead compound, CAT-2003, a modulator of the lipid synthesis pathway, which is currently in a Phase 2 clinical trial in patients with hypertriglyceridemia and in combination with statins in patients with hypercholesterolemia. Catabasis also plans to use the proceeds to support the continued clinical and pre-clinical development of other SMART Linker conjugates in the pipeline.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. B14202
Cambridge, MA 02139
USA
Phone
(617) 349-1971
Website
www.catabasis.com
Email Address
[email protected]
Overview
At Catabasis (NASDAQ: CATB) we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients.
Profile
Catabasis Pharmaceuticals LinkedIn Company Profile
Social Media
Catabasis Pharmaceuticals Company Twitter Account
Company News
Catabasis Pharmaceuticals News
Facebook
Catabasis Pharmaceuticals on Facebook
YouTube
Catabasis Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jill Milne
  Jill Milne LinkedIn Profile  Jill Milne Twitter Account  Jill Milne News  Jill Milne on Facebook
Chief Financial Officer
Ian Sanderson
  Ian Sanderson LinkedIn Profile  Ian Sanderson Twitter Account  Ian Sanderson News  Ian Sanderson on Facebook
Chief Medical Officer
Joanne Donovan
  Joanne Donovan LinkedIn Profile  Joanne Donovan Twitter Account  Joanne Donovan News  Joanne Donovan on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/14/2013: Genapsys venture capital transaction
Next: 11/14/2013: nexgrid venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.